News

Podcast

Pharmacy Focus: Oncology Edition – Key Insights and Interviews From the 2024 SABCS Meeting

Author(s):

Alexandra Gerlach, Associate Editor

Pharmacy Times attended the 2024 San Antonio Breast Cancer Symposium from December 10 to December 13.

This episode of Pharmacy Focus: Oncology Edition highlights key insights from the 2024 San Antonio Breast Cancer Symposium, covering new FDA-approved therapies, dose optimization strategies, and innovative prevention approaches in breast cancer care.

Related Videos
California Wildfire, Pharmacy, Community | Image Credit: Erin | stock.adobe.com
Allergies, Asthma, Biologic Treatment, Pharmacists | Image Credit: Pixel-Shot | stock.adobe.com
Woman professional nutritionist checking dietary supplements in hand, surrounded by a variety of fruits, nuts, vegetables, and dietary supplements on the table - Image credit: amenic181 | stock.adobe.com
Related Content
Red blood cells, hematology -- Image credit: Rasi | stock.adobe.com
January 19th 2025

From Blinatumomab to Venetoclax: Highlights From the 66th American Society of Hematology Annual Meeting and Exposition

Douglas Braun, PharmD, RPh, CPH, CSP
Public Health Matters: The Importance of Reproductive Justice and Black Maternal Health
December 24th 2024

Public Health Matters: The Importance of Reproductive Justice and Black Maternal Health

Christina M. Madison, PharmD, FCCP, AAHIVP
FDA US Food and Drug website in browser with company logo | Image Credit: © Postmodern Studio - stock.adobe.com
January 17th 2025

FDA’s Accelerated Approval Pathway Under Scrutiny for Key Drug Approvals

Alexandra Gerlach, Associate Editor
Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments
November 25th 2024

Pharmacy Focus: Oncology Edition - Discussing Increasing Rates of Lung Cancer in Young Adults and Emerging Precision Treatments

FDA approval seal -- Image credit: Aquir | stock.adobe.com
January 17th 2025

FDA Approves Dato-DXd for Adults With Unresectable or Metastatic HR+, HER2- Breast Cancer

Gillian McGovern, Associate Editor
Close up male hand holding a cigarette - Image credit: Nopphon | stock.adobe.com
January 17th 2025

FDA Targets Nicotine to Reduce Lung Cancer and Other Tobacco-Related Diseases

Kennedy Ferruggia, Assistant Editor